Data / Form D filings / Icagen-T, Inc.
Icagen-T, Inc.: Form D filings
Icagen-T, Inc., a pharmaceuticals company in Oro Valley, AZ, filed 2 Form D notices with the SEC between 2017 and 2018. The latest, on September 12, 2018, reports $8 million sold of a $8 million offering to 1 investor.
Find out what Icagen-T, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2090 E. INNOVATION PARK DRIVE, Oro Valley, AZ, 85755
- Phone
- (520) 544-6800
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1707449
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 12, 2018 | New notice | $8,000,000 | $8,000,000 | $0 | 1 | Aug 31, 2018 | sec.gov |
| May 25, 2017 | New notice | $8,000,000 | $8,000,000 | $0 | 1 | May 15, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Timothy Tyson | Director | |
| Mark Korb | Executive Officer, Director | |
| Douglas Krafte | Director | |
| Richard Cunningham | Executive Officer, Director |
Every Form D from the week of Sep 10, 2018 · All recent filings in Arizona · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Icagen-T, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.